Cargando…
How should molecular findings be integrated in the classification for lung cancer?
The use of molecular diagnostics in the diagnosis and management of patients with advanced lung cancer has become widespread. Although molecular classification has increasingly been incorporated in the pathologic classification of certain types of human tumors (particularly within the hematologic, g...
Autores principales: | Hung, Yin P., Chirieac, Lucian R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653151/ https://www.ncbi.nlm.nih.gov/pubmed/33209647 http://dx.doi.org/10.21037/tlcr-20-153 |
Ejemplares similares
-
New molecular classification of large cell neuroendocrine carcinoma and small cell lung carcinoma with potential therapeutic impacts
por: Lantuejoul, Sylvie, et al.
Publicado: (2020) -
New developments in lung cancer diagnosis and pathological patient management strategies
por: Popper, Helmut
Publicado: (2020) -
Outsourcing predictive biomarker testing in non-small cell carcinoma: a personal view of pathologists
por: Brcic, Luka, et al.
Publicado: (2020) -
New insights into the interaction of the immune system with non-small cell lung carcinomas
por: Hofman, Paul
Publicado: (2020) -
Primary tumor and metastasis—sectioning the different steps of the metastatic cascade
por: Popper, Helmut
Publicado: (2020)